FDA Approves BioImagene Device

Digital pathology company BioImagene Inc. said it received clearance from the Food and Drug Administration for its Pathiam System with iScan for assessment of HER2/neu immunohistochemistry tests.
Silicon Valley/San Jose Business Journal